252 related articles for article (PubMed ID: 15325920)
1. Lycopene: modes of action to promote prostate health.
Wertz K; Siler U; Goralczyk R
Arch Biochem Biophys; 2004 Oct; 430(1):127-34. PubMed ID: 15325920
[TBL] [Abstract][Full Text] [Related]
2. Lycopene effects contributing to prostate health.
Wertz K
Nutr Cancer; 2009; 61(6):775-83. PubMed ID: 20155615
[TBL] [Abstract][Full Text] [Related]
3. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
[TBL] [Abstract][Full Text] [Related]
4. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.
Karas M; Amir H; Fishman D; Danilenko M; Segal S; Nahum A; Koifmann A; Giat Y; Levy J; Sharoni Y
Nutr Cancer; 2000; 36(1):101-11. PubMed ID: 10798222
[TBL] [Abstract][Full Text] [Related]
5. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate.
Herzog A; Siler U; Spitzer V; Seifert N; Denelavas A; Hunziker PB; Hunziker W; Goralczyk R; Wertz K
FASEB J; 2005 Feb; 19(2):272-4. PubMed ID: 15545302
[TBL] [Abstract][Full Text] [Related]
6. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.
Barber NJ; Zhang X; Zhu G; Pramanik R; Barber JA; Martin FL; Morris JD; Muir GH
Prostate Cancer Prostatic Dis; 2006; 9(4):407-13. PubMed ID: 16983396
[TBL] [Abstract][Full Text] [Related]
7. Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes.
Goyal A; Delves GH; Chopra M; Lwaleed BA; Cooper AJ
BJU Int; 2006 Oct; 98(4):907-11. PubMed ID: 16978292
[TBL] [Abstract][Full Text] [Related]
8. Lycopene in the prevention of prostate cancer.
Dahan K; Fennal M; Kumar NB
J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
[TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
10. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model.
Siler U; Barella L; Spitzer V; Schnorr J; Lein M; Goralczyk R; Wertz K
FASEB J; 2004 Jun; 18(9):1019-21. PubMed ID: 15084515
[TBL] [Abstract][Full Text] [Related]
11. Drug Insight: lycopene in the prevention and treatment of prostate cancer.
Guns ES; Cowell SP
Nat Clin Pract Urol; 2005 Jan; 2(1):38-43. PubMed ID: 16474575
[TBL] [Abstract][Full Text] [Related]
12. Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells.
Liu X; Allen JD; Arnold JT; Blackman MR
Carcinogenesis; 2008 Apr; 29(4):816-23. PubMed ID: 18283040
[TBL] [Abstract][Full Text] [Related]
13. Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells.
Gunasekera RS; Sewgobind K; Desai S; Dunn L; Black HS; McKeehan WL; Patil B
Nutr Cancer; 2007; 58(2):171-7. PubMed ID: 17640163
[TBL] [Abstract][Full Text] [Related]
14. Are lycopene metabolites metabolically active?
Ford NA; Erdman JW
Acta Biochim Pol; 2012; 59(1):1-4. PubMed ID: 22428115
[TBL] [Abstract][Full Text] [Related]
15. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
17. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells.
Hwang ES; Bowen PE
J Med Food; 2004; 7(3):284-9. PubMed ID: 15383220
[TBL] [Abstract][Full Text] [Related]
19. Lycopene effects on rat normal prostate and prostate tumor tissue.
Siler U; Herzog A; Spitzer V; Seifert N; Denelavas A; Hunziker PB; Barella L; Hunziker W; Lein M; Goralczyk R; Wertz K
J Nutr; 2005 Aug; 135(8):2050S-2S. PubMed ID: 16046739
[No Abstract] [Full Text] [Related]
20. Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells.
Tang FY; Cho HJ; Pai MH; Chen YH
J Nutr Biochem; 2009 Jun; 20(6):426-34. PubMed ID: 18708285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
